Material Type

• Blood (whole) (5)
• Buffy coat (1)
• Dried whole blood (3)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Other (3)
• Plasma (double spun) (1)
• Plasma (single spun) (5)
• Red Blood Cells (1)
• Saliva (2)
• Serum (5)
• Swab medium (2)
• Urine (first morning) (1)
• Urine (random) (2)

Microscopic Assessment

• Affected (2)
• Not applicable (7)

Storage Temperature

• RT (2)
• -35°C to -18°C (2)
• -85°C to -60°C (7)

Preservation Type

• N/A (2)

Associated Data

• Biomarker datasets (2)
• Clinical records (8)
• Followup records (6)
• Freezer temperature logs (5)
• Genomic datasets (1)
• Imaging data (1)
• Microbiological results (5)
• Participant Ethnicity (4)
• Physiological/biochemical measurements (5)
• Pre-analytical data (3)
• Primary care records (1)
• Quality indicators (4)
• Survey data (3)
• Treatment records (3)

Timeframe

• Immediate (4)
• 0 - 3 months (6)
• 3 - 6 months (4)
• > 6 months (2)

Participant Count

• 101 - 500 (8)

Sex

• Both sexes (8)

Age Range

• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (1)
• Adolescent (12 - 18 years) (1)
• Young adult (18 - 40 years) (6)
• Adult (> 40 years) (1)

Biobank Services

• Ability to recontact (3)
• Cell culture (2)
• Data analytics (2)
• Digital imaging (1)
• Nucleic acid extraction (1)

Collection Type

• Case-control (1)
• Clinical Trial (2)
• Cross-sectional (1)
• Disease specific (4)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (6)
• No Genetic analysis restriction (8)
• No Human genetic analysis restriction (8)
• No restrictions (1)
• No Project specific restriction (7)
• No Scope of use restriction (4)

Collection Status

• Completed (4)
• In progress (5)

Access Condition

• Open to applicants (4)
• Open only through collaboration (5)
• Access restricted at present (1)

Country

• Belgium (1)
• Brazil (1)
• Democratic Republic of the Congo (2)
• Peru (1)
• South Africa (1)
• Spain (1)
• Switzerland (1)

County